These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26778259)

  • 1. Thrombolytic Use in Children: Breaking Down Barriers.
    Crystal MA
    J Pediatr; 2016 Apr; 171():12-3. PubMed ID: 26778259
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective thrombolytic therapy with a tissue activator of plasminogen].
    Carreras LO
    Medicina (B Aires); 1985; 45(3):309-11. PubMed ID: 3939429
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease.
    Tsubata S; Ichida F; Hamamichi Y; Miyazaki A; Hashimoto I; Okada T
    Pediatr Cardiol; 1995; 16(4):186-9. PubMed ID: 7567665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator for prosthetic mitral-valve thrombosis.
    Astengo D; Badano L; Bertoli D
    N Engl J Med; 1995 Jul; 333(4):259. PubMed ID: 7791853
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant.
    Weinschenk N; Pelidis M; Fiascone J
    Am J Perinatol; 2001 Aug; 18(5):293-7. PubMed ID: 11552182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial occlusions.
    Dawson KJ; Hamilton G
    Radiology; 1991 Jan; 178(1):283-4. PubMed ID: 1898537
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tissue-type plasminogen activator--a fibrinolytic preparation].
    Makarov VA
    Farmakol Toksikol; 1989; 52(2):90-3. PubMed ID: 2501106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Plasminogen Activator Use in Children: Bleeding Complications and Thrombus Resolution.
    Ansah DA; Patel KN; Montegna L; Nicholson GT; Ehrlich AC; Petit CJ
    J Pediatr; 2016 Apr; 171():67-72.e1-2. PubMed ID: 26707578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful local thrombolysis of an acutely thrombosed AV fistula by recombinant human tissue plasminogen activator.
    Vlassopoulos D; Magana P; Logothetis E; Hadjiconstantinou V
    Nephrol Dial Transplant; 1993; 8(4):380-1. PubMed ID: 8390026
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
    Özkan M; Çakal B; Karakoyun S; Gürsoy OM; Çevik C; Kalçık M; Oğuz AE; Gündüz S; Astarcioglu MA; Aykan AÇ; Bayram Z; Biteker M; Kaynak E; Kahveci G; Duran NE; Yıldız M
    Circulation; 2013 Jul; 128(5):532-40. PubMed ID: 23812180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tissue type plasminogen activator in neonates: case reports and review of the literature.
    Smets K; Vanhaesebrouck P; Voet D; Schelstraete P; Govaert P
    Am J Perinatol; 1996 May; 13(4):217-22. PubMed ID: 8724722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients.
    Vlassopoulos D; Logothetis E; Arvanitis D; Noussias C; Magana P; Katopodis K; Hadjiconstantinou V
    Clin Nephrol; 1996 Jul; 46(1):77-8. PubMed ID: 8832159
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of T-PA on thrombosis, an experimental study].
    Gu YD
    Zhonghua Wai Ke Za Zhi; 1991 Oct; 29(10):605-7, 652-3. PubMed ID: 1815902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator. Mechanisms of action and thrombolytic properties.
    Collen D; Lijnen HR
    Haemostasis; 1986; 16 Suppl 3():25-32. PubMed ID: 3095195
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local intravenous thrombolysis with recombinant tissue plasminogen activator for salvage of forearm replantation.
    Hashim HA; Atiyeh BS; Hamdan AM; Musharrafieh RS
    J Reconstr Microsurg; 1996 Nov; 12(8):543-6. PubMed ID: 8951123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombosis of mechanical tricuspid valve prosthesis: treatment by tissue-type plasminogen activator. Success after a 18 month-follow-up].
    Silva A; Jais JM
    Arch Mal Coeur Vaiss; 1994 Jun; 87(6):813-7. PubMed ID: 7702426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The new thrombolytic agents].
    Bassand JP
    Ann Cardiol Angeiol (Paris); 1989 Sep; 38(7 Pt 2):487-91. PubMed ID: 2511796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.